ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['lenalidomide', ' lena', 'cartitude-4', 'mmsm', 'multiplemyeloma', 'cartitude', 'ciltacabtagene autoleucel']
cartitude-4 results unveiled at #asco23: pfs benefit seen with ciltacabtagene autoleucel in lenalidomide-refractory #multiplemyeloma: #ascodailynews #mmsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.